Pseudomonas aeruginosa extracellular toxicity in infant mice and the protective effect of antitoxin A

A R Ogaard1, B P Berdal

  • 1Norwegian Defence Microbiological Laboratory, National Institute of Public Health, Oslo.

Insights

Pseudomonas aeruginosa toxin A levels were measured by ELISA. Antitoxin A serum protected infant mice from toxin A, but its effectiveness did not correlate with ELISA measurements.

Area of Science:

  • Microbiology
  • Immunology
  • Toxicology

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen known for producing various toxins.
  • Toxin A is a key virulence factor contributing to P. aeruginosa pathogenesis.
  • Accurate quantification of toxin A and assessment of antitoxin efficacy are crucial for understanding disease mechanisms and developing treatments.

Purpose of the Study:

  • To quantify Toxin A content in Pseudomonas aeruginosa extracellular preparations using ELISA.
  • To evaluate the in vivo toxicity of these preparations in infant mice.
  • To determine the protective efficacy of rabbit antitoxin A serum against Toxin A.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was employed to measure Toxin A concentration.
  • Infant mice were used as a model system to assess the lethal dose 50 (LD50) of toxin preparations.
  • Neutralization assays were performed by co-administering purified Toxin A with rabbit antitoxin A serum.

Main Results:

  • The LD50 of purified Toxin A in infant mice was determined to be 80 ng.
  • Administration of 10 microliters of rabbit antitoxin A serum increased the LD50 to 2,500 ng.
  • A significant lack of correlation was observed between ELISA-determined Toxin A levels, LD50 values, and the protective effect of antitoxin A.

Conclusions:

  • ELISA is a reliable method for quantifying Toxin A in P. aeruginosa preparations.
  • Antitoxin A serum demonstrates significant neutralizing capacity against Toxin A in vivo.
  • The study highlights a discrepancy between in vitro toxin quantification and in vivo protective immunity, suggesting complex interactions in Pseudomonas aeruginosa infections.

Related Concept Videos